Janney Montgomery Scott’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$660K Sell
69,896
-1,800
-3% -$14.4K ﹤0.01% 2194
2026
Q2
$628K Buy
71,696
+759
+1% +$5.74K ﹤0.01% 2242
2026
Q1
$544K Buy
70,937
+47,006
+196% +$322K ﹤0.01% 1992
2025
Q4
$47K Buy
+23,931
New +$54.2K ﹤0.01% 2891

Other funds holding IBRX

Janney Montgomery Scott's IBRX Position: Q3 2026 in Review

Janney Montgomery Scott reduced its ImmunityBio (IBRX) stake by 2.5% in Q3 2026, selling an estimated $14.4K and leaving 69,896 shares worth $660K. The position accounts for ﹤0.01% of the portfolio, ranked #2194.

Janney Montgomery Scott first reported a position in IBRX in Q4 2025 and has held it in 4 quarters since. 321 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.

  • Janney Montgomery Scott held 69,896 shares of ImmunityBio worth $660K as of Q3 2026.
  • Janney Montgomery Scott sold 1,800 ImmunityBio shares in Q3 2026, an estimated $14.4K.
  • ImmunityBio made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q3 2026, its #2194 holding.
  • Janney Montgomery Scott first reported a position in ImmunityBio in Q4 2025 and has held it in 4 quarters since.
  • 321 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.

Based on Janney Montgomery Scott's 13F filing for Q3 2026, filed 12 Nov 2026.